Myristoylation of gag proteins of HIV-1 plays an important role in virus assembly
about
The interferon response inhibits HIV particle production by induction of TRIM22HIV type 1 Gag as a target for antiviral therapyEfficient particle formation can occur if the matrix domain of human immunodeficiency virus type 1 Gag is substituted by a myristylation signalAn assembly domain of the Rous sarcoma virus Gag protein required late in buddingRole of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infectionSingle amino acid changes in the human immunodeficiency virus type 1 matrix protein block virus particle productionLipids and membrane microdomains in HIV-1 replicationHEED, the product of the human homolog of the murine eed gene, binds to the matrix protein of HIV-1Opposing effects of human immunodeficiency virus type 1 matrix mutations support a myristyl switch model of gag membrane targeting.Binding of human immunodeficiency virus type 1 Gag to membrane: role of the matrix amino terminus.Contribution of virus-like particles to the immunogenicity of human immunodeficiency virus type 1 Gag-derived vaccines in miceRole of matrix in an early postentry step in the human immunodeficiency virus type 1 life cycle.Detection of a trimeric human immunodeficiency virus type 1 Gag intermediate is dependent on sequences in the matrix protein, p17.Analysis of minimal human immunodeficiency virus type 1 gag coding sequences capable of virus-like particle assembly and release.A bipartite membrane-binding signal in the human immunodeficiency virus type 1 matrix protein is required for the proteolytic processing of Gag precursors in a cell type-dependent mannerCleavage of the murine leukemia virus transmembrane env protein by human immunodeficiency virus type 1 protease: transdominant inhibition by matrix mutations.Role of the Gag matrix domain in targeting human immunodeficiency virus type 1 assembly.Formation of virus assembly intermediate complexes in the cytoplasm by wild-type and assembly-defective mutant human immunodeficiency virus type 1 and their association with membranes.Substitution of the myristoylation signal of human immunodeficiency virus type 1 Pr55Gag with the phospholipase C-delta1 pleckstrin homology domain results in infectious pseudovirion production.Activation of the Mason-Pfizer monkey virus protease within immature capsids in vitroThe Role of Lipids in Retrovirus Replication.Identification of a protective CD4+ T-cell epitope in p15gag of Friend murine leukemia virus and role of the MA protein targeting the plasma membrane in immunogenicityp6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing proteaseCoding sequences upstream of the human immunodeficiency virus type 1 reverse transcriptase domain in Gag-Pol are not essential for incorporation of the Pr160(gag-pol) into virus particles.Deletions in the fifth alpha helix of HIV-1 matrix block virus release.Hydrogen bonding at a conserved threonine in lentivirus capsid is required for virus replication.Characterization of human immunodeficiency virus type 1 Pr55gag membrane association in a cell-free system: requirement for a C-terminal domain.Human immunodeficiency virus type 1 MA deletion mutants expressed in baculovirus-infected cells: cis and trans effects on the Gag precursor assembly pathway.Sequence requirements for encapsidation of deletion mutants and chimeras of human immunodeficiency virus type 1 Gag precursor into retrovirus-like particles.Transport and processing of the Rous sarcoma virus Gag protein in the endoplasmic reticulum.Incorporation of human immunodeficiency virus type 1 reverse transcriptase into virus-like particlesRelease of virus-like particles from cells infected with poliovirus replicons which express human immunodeficiency virus type 1 GagPhase I safety and immunogenicity evaluations of an alphavirus replicon HIV-1 subtype C gag vaccine in healthy HIV-1-uninfected adults.Inhibition of early and late events of the HIV-1 replication cycle by cytoplasmic Fab intrabodies against the matrix protein, p17Phenotypic characterization of insertion mutants of the human immunodeficiency virus type 1 Gag precursor expressed in recombinant baculovirus-infected cells.Specificity and sequence requirements for interactions between various retroviral Gag proteins.Assembly, processing, and infectivity of human immunodeficiency virus type 1 gag mutants.Functional chimeras of the Rous sarcoma virus and human immunodeficiency virus gag proteinsConditional infectivity of a human immunodeficiency virus matrix domain deletion mutant.Characterization of monoclonal antibodies against the human immunodeficiency virus matrix protein, p17gag: identification of epitopes exposed at the surfaces of infected cells.
P2860
Q21131598-FF8C8716-279C-4351-BBF3-D69A257F7B14Q24614498-CF354358-0464-4CE8-ABDA-215A67E4034EQ24645635-B7CD8645-9DB4-48EB-9776-78D41D31CE64Q24645654-B675F092-6C13-4805-A019-DDFE84FE72E5Q24673913-F38E3D74-0308-4F03-BA46-536C062F3F77Q27485930-620AA901-3D45-46C5-BD36-EE3F99FFF4C6Q27489393-FC967AA2-C694-4AC1-B870-63C775DAAD63Q28293190-0AD163CE-E3C6-4E01-B946-40E465034D0FQ33642818-BFB571D4-806D-40C6-8826-CFAD98F5EE5FQ33647588-5DACC8F5-F8E8-48E2-90D2-4F24270AC785Q33717736-0BA32D2B-8BB2-4EF7-880D-71E33C30D520Q33782781-7D3FDE92-752F-44AE-8B7A-8FC1432AFFE6Q33784101-7E053D0B-3996-4ADB-8E3E-9DF8D4388E9AQ33784754-10906E60-CBAD-4708-8848-573F617714E3Q33785367-70511BFC-BE7E-486C-AFE0-7AB6A62C9C95Q33785977-04B350F1-BE43-4073-AC49-3879E180CC58Q33800293-424328D8-72CE-4AC3-BC84-E40A3D15DA03Q33815436-A6705577-CFBB-4705-9491-893AAA2DD580Q33910600-6757A782-7276-40AF-A2F4-612FCE4FD40DQ33952099-F906DCA5-032F-4D4F-958C-7858EE266088Q34080779-0BAE2414-5677-4ED9-B611-5E7F6FAC90F9Q34186587-E78DBAAD-16DD-4337-AEA7-831A0E209C3BQ34288376-33C5BA74-FDA4-4D30-95CB-DEEB4693E856Q34334594-E1C1CCC3-A848-4D1E-BC68-673870A2BD7CQ34620716-AFBF6D8A-020F-407A-BACC-79B64CA6AB80Q35104668-5A1D6365-661F-4144-BF62-8E6EF09E74C5Q35248506-1E3F8C29-64D2-4B8C-9854-94079873AA41Q35829873-A5F9A345-CA8D-404A-AB4E-F39E91553473Q35837753-48F770DA-16DB-4ED8-B372-BC5B4BB5388AQ35856473-CCC1E242-FD42-4CF7-A1C7-5681769552C6Q35857486-F8A2C1D2-52F7-4A91-9328-084F081AA723Q35859503-032FAAAA-CE94-48DB-A811-55708651F639Q36362287-9AB40BF2-5DD9-4310-BCD0-34711BA96CD9Q36437723-0AECB4DF-1AD2-4591-BEE0-FFB985C67EAEQ36619015-5B98391F-7228-48BD-8130-5050CC7319AFQ36626107-AA62D35D-3C2A-4178-A22E-713D97028C6EQ36650299-8E5B6C91-F943-4148-A2B0-1DD4C9D7E08BQ36654259-EEDF120D-8A9A-48D3-B390-EE0CD2DD9059Q36654963-F30EB555-65A1-49DF-8FDF-89BD41144EA3Q36797706-C8D9DCDE-01D3-4B90-B400-FBB9A2C692B5
P2860
Myristoylation of gag proteins of HIV-1 plays an important role in virus assembly
description
1990 nî lūn-bûn
@nan
1990 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Myristoylation of gag proteins of HIV-1 plays an important role in virus assembly
@ast
Myristoylation of gag proteins of HIV-1 plays an important role in virus assembly
@en
Myristoylation of gag proteins of HIV-1 plays an important role in virus assembly
@nl
type
label
Myristoylation of gag proteins of HIV-1 plays an important role in virus assembly
@ast
Myristoylation of gag proteins of HIV-1 plays an important role in virus assembly
@en
Myristoylation of gag proteins of HIV-1 plays an important role in virus assembly
@nl
prefLabel
Myristoylation of gag proteins of HIV-1 plays an important role in virus assembly
@ast
Myristoylation of gag proteins of HIV-1 plays an important role in virus assembly
@en
Myristoylation of gag proteins of HIV-1 plays an important role in virus assembly
@nl
P2093
P3181
P356
P1476
Myristoylation of gag proteins of HIV-1 plays an important role in virus assembly
@en
P2093
F D Veronese
M G Sarngadharan
P304
P3181
P356
10.1089/AID.1990.6.721
P407
P577
1990-06-01T00:00:00Z